NuVision

NuVision® (www.nu-vision.co.uk) is a regenerative medicine company recently spun-out from the University of Nottingham. The company was established to commercialise high quality and affordable biotherapies for treating ‘front of the eye’ disease and trauma. NuVision clean room clinical manufacturing laboratories, licenced by the Human Tissue Authority (HTA) and offices are based at MediCity, Boots Enterprise Zone in Nottingham.

NuVision is unique in that we are the UK’s first ophthalmology focused regenerative medicine company, formed from and supported by a world leading academic corneal research and development group at the University of Nottingham

The company’s launch product is Omnigen®, a biological wound dressing which aids the regeneration and healing of the surface of the eye. Omnigen is a first of its kind human amniotic membrane-derived dry preserved biological wound dressing which is set to revolutionise the clinical management corneal disease.